Nelsen Robert

-

Assets, Funds, Holdings

Home | Sign Up | Log In
⚲
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Nelsen Robert
✚
CIK #0001219042
EDGAR Form CIK 2011 - 2026
3 [0001219042]
4 [0001219042]
Form 3/4/5 Subject 2011 - 2026
Bybee Clinton
Burow Kristina
Nelsen Robert
Gillis Steven
Boundless Bio Inc
Crandell Keith
Arch Venture Partners XIII LLC
Kardigan Inc
Arch Venture Partners XIII LP
Arch Venture Fund XIII LP
Prime Medicine Inc
Sana Biotechnology Inc
Arch Venture Fund XII LP
Arch Venture Partners XII LLC
Seaport Therapeutics Inc
Arch Venture Partners XII LP
Berns Paul L
Lyell Immunopharma Inc
Metsera Inc
Neumora Therapeutics Inc
Arch Venture Partners IX LLC
Arch Venture Partners IX Overage LP
Arch Venture Fund IX Overage LP
Arch Venture Partners IX LP
Arch Venture Fund IX LP
Arch Venture Partners X LLC
Maze Therapeutics Inc
Arch Venture Fund X Overage LP
Arch Venture Partners X LP
Arch Venture Fund X LP
Arch Venture Partners X Overage LP
Rapport Therapeutics Inc
Vir Biotechnology Inc
DA32 Life Science Tech Acquisition Corp
Arch Venture Partners XI LLC
Arch Venture Partners XI LP
Arch Venture Fund XI LP
Arch Venture Partners VIII LP
Arch Venture Partners VIII LLC
Codiak BioSciences Inc
Arch Venture Fund VIII Overage LP
Arch Venture Fund VIII LP
Erasca Inc
Beam Therapeutics Inc
Verve Therapeutics Inc
Denali Therapeutics Inc
Karuna Therapeutics Inc
Revolution Healthcare Acquisition Corp
908 Devices Inc
Arch Venture Fund VII LP
Arch Venture Partners VII LP
Arch Venture Partners VII LLC
Quanterix Corp
Arch Venture Partners VI LP
Arch Venture Fund VI LP
Arch Venture Partners VI LLC
Metacrine Inc
Unity Biotechnology Inc
Syros Pharmaceuticals Inc
Q32 Bio Inc
Sienna Biopharmaceuticals Inc
Gossamer Bio Inc
Twist Bioscience Corp
Scholar Rock Holding Corp
Pulmatrix Inc
Juno Therapeutics Inc
Agios Pharmaceuticals Inc
Xtera Communications Inc
Arch Venture Partners V LLC
Arch V Entrepreneurs Fund LP
Arch Venture Partners V LP
Lazarus Steven
Impinj Inc
Arch Venture Fund V LP
Phaserx Inc
Sage Therapeutics Inc
Adesto Technologies Corp
VBI Vaccines Inc
Kythera Biopharmaceuticals Inc
Bellerophon Therapeutics Inc
Receptos Inc
Achaogen Inc
Fate Therapeutics Inc
bluebird bio Inc
NeurogesX Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Lyell Immunopharma Inc LYEL
Common Stock
2026-03-06 Buy 488,090 $25.61 12,499,985
Metsera Inc MTSR
Common Stock
2025-11-13 Disposed to issuer 18,503,128
Metsera Inc MTSR
Common Stock
2025-11-13 Disposed to issuer 8,313,680
Neumora Therapeutics Inc NMRA
Common Stock
2025-10-27 Buy 1,915,700 $2.61 4,999,977
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
2025-08-01 Disposed to issuer 45,000
Prime Medicine Inc PRME
Common Stock
2025-08-01 Buy 3,030,300 $3.30 9,999,990
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
2025-08-01 Disposed to issuer 39,062
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
2025-08-01 Grant 45,000
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
2025-08-01 Grant 39,062
Sana Biotechnology Inc SANA
Stock Option (Right to Buy) · derivative
2025-06-05 Grant 80,000 $0.00
Prime Medicine Inc PRME
Stock Option (right to buy) · derivative
2025-06-04 Grant 55,000 $0.00
Metsera Inc MTSR
Common Stock
2025-02-03 Conversion 7,523,682
Metsera Inc MTSR
Common Stock
2025-02-03 Buy 789,998 $18.00 14,219,964
Metsera Inc MTSR
Series Seed Preferred Stock · derivative
2025-02-03 Conversion 19,933,333
Metsera Inc MTSR
Series B Convertible Preferred Stock · derivative
2025-02-03 Conversion 2,678,571
Metsera Inc MTSR
Series A Convertible Preferred Stock · derivative
2025-02-03 Conversion 15,000,000
Metsera Inc MTSR
Common Stock
2025-02-03 Buy 1,432,224 $18.00 25,780,032
Metsera Inc MTSR
Series A Convertible Preferred Stock · derivative
2025-02-03 Conversion 15,000,000
Metsera Inc MTSR
Common Stock
2025-02-03 Conversion 16,006,949
Metsera Inc MTSR
Series B Convertible Preferred Stock · derivative
2025-02-03 Conversion 2,678,571
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com